Display options
Cite
McNeil CJ, Tan A, Powell JA, et al. Evaluating the efficacy of eradicating Gardnerella vaginalis (GV) vaginal colonization with amoxicillin; a randomized, double-blind, phase 2 study. Sex Transm Dis. 2021;doi: 10.1097/OLQ.0000000000001555.
McNeil, C. J., Tan, A., Powell, J. A., Pontius, A., Lewis, A., Myler, N., & Schwebke, J. R. (2021). Evaluating the efficacy of eradicating Gardnerella vaginalis (GV) vaginal colonization with amoxicillin; a randomized, double-blind, phase 2 study. Sexually transmitted diseases, . https://doi.org/10.1097/OLQ.0000000000001555
McNeil, Candice J, et al. "Evaluating the efficacy of eradicating Gardnerella vaginalis (GV) vaginal colonization with amoxicillin; a randomized, double-blind, phase 2 study." Sexually transmitted diseases vol. (2021). doi: https://doi.org/10.1097/OLQ.0000000000001555
McNeil CJ, Tan A, Powell JA, Pontius A, Lewis A, Myler N, Schwebke JR. Evaluating the efficacy of eradicating Gardnerella vaginalis (GV) vaginal colonization with amoxicillin; a randomized, double-blind, phase 2 study. Sex Transm Dis. 2021 Aug 31; doi: 10.1097/OLQ.0000000000001555. Epub 2021 Aug 31. PMID: 34475360.
Copy Download .nbib Format: NLM
Share it on

Sex Transm Dis. 2021 Aug 31; doi: 10.1097/OLQ.0000000000001555. Epub 2021 Aug 31.

Evaluating the efficacy of eradicating Gardnerella vaginalis (GV) vaginal colonization with amoxicillin; a randomized, double-blind, phase 2 study.

Sexually transmitted diseases

Candice J McNeil, Amy Tan, Jonathan A Powell, Angela Pontius, Andrea Lewis, Noelle Myler, Jane R Schwebke

Affiliations

  1. Wake Forest University Health Sciences, Winston Salem, NC The Emmes Company, LLC, Rockville, MD University of Alabama Birmingham, Birmingham, AL FHI 360, Durham, NC.

PMID: 34475360 DOI: 10.1097/OLQ.0000000000001555

Abstract

BACKGROUND: Research suggests that Gardnerella vaginalis (GV) is the keystone pathogen in bacterial vaginosis (BV). Knowledge gaps exist regarding the role of GV eradication in the development of BV. This study was designed to test the hypothesis that vaginal colonization with GV could be eradicated by treatment of women without BV with amoxicillin, a drug highly active against GV. If GV is necessary for the development of BV, then eradication of GV may prevent the development of BV.

METHODS: We conducted a randomized control trial of amoxicillin 500 mg twice daily versus placebo for 7 days in women ages 18-45 without vaginitis who screened positive for vaginal colonization with GV by qPCR. Test-of-cure visit for GV was conducted at day 21.

RESULTS: 172 women met preliminary criteria and were screened for enrollment. Ninety-seven GV positive women were randomized to receive amoxicillin versus placebo. Eradication of GV occurred in 21% of women randomized to amoxicillin versus 16% on placebo (p = 0.757). In the 4 weeks between screening and test-of-cure visit, 16/92 (17%) of participants developed Nugent scores >3 with 8/92 (9%) having BV. All of these were in participants in whom GV was not eradicated (p = 0.035).

CONCLUSIONS: The study failed to show a benefit of treatment with amoxicillin to eradicate GV. No participants in whom GV was eradicated had progression to abnormal vaginal flora during the study period.

Copyright ©2021 American Sexually Transmitted Diseases Association.

Conflict of interest statement

Conflict of Interest: None

Publication Types